{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:45:25Z","timestamp":1786736725832,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger Postgrad Med J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/npmj.npmj_241_20","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T04:06:49Z","timestamp":1604462809000},"page":"325","source":"Crossref","is-referenced-by-count":5,"title":["CA125 levels in pregnancy: A case-control study amongst pregnant women in Aminu Kano teaching hospital, North-West Nigeria"],"prefix":"10.4103","volume":"27","author":[{"given":"IdrisUsman","family":"Takai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BadiaMaje","family":"Sayyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaiduAdamu","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabiru","family":"Abdulsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UsmanMuhammad","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1117-1936.299912-1","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Glilstrap LC. Hypertensive disorders in pregnancy. In: Williams Obstetrics. 22nd ed. New York: Mcgraw-Hill; 2005. p. 761-808."},{"key":"key-10.4103\/1117-1936.299912-2","first-page":"b2255","volume-title":"Risk of preelampsia in first and subsequent pregnancies: Prospective cohort study","author":"Hernandaz-Diaz","year":"2009","journal-title":"BMJ"},{"key":"key-10.4103\/1117-1936.299912-3","first-page":"467","volume-title":"Preeclampsia: Pathophysiology, diagnosis and management","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/1117-1936.299912-4","first-page":"29","volume-title":"Relation between preclampsia and cardiac enzymes","author":"Aziz","year":"2008","journal-title":"Arya Arthur J"},{"key":"key-10.4103\/1117-1936.299912-5","first-page":"104","volume-title":"Management of eclampsia at AKTH: Before and after magnesium sulphate","author":"Tukur","year":"2010","journal-title":"Niger J Med","ISSN":"https:\/\/id.crossref.org\/issn\/1115-2613","issn-type":"print"},{"key":"key-10.4103\/1117-1936.299912-6","first-page":"305","volume-title":"Maternal and fetal outcome in patients with eclampsia at Murtala Muhammad specialist Hospital Kano, Nigeria","author":"Yakasai","year":"2011","journal-title":"Ann Afr Med","ISSN":"https:\/\/id.crossref.org\/issn\/1596-3519","issn-type":"print"},{"key":"key-10.4103\/1117-1936.299912-7","first-page":"83","volume-title":"Maternal mortality in a Nigeria teaching hospital-A continuing tragedy","author":"Aboyeji","year":"2007","journal-title":"Trop Doct"},{"key":"key-10.4103\/1117-1936.299912-8","doi-asserted-by":"crossref","unstructured":"Jason J, Waugh S, Smith M. Hypertensive disorders. In: Dewhursts Textbook of Obstetrics and Gynaecology. 8th ed. Oxford: Blackwell Publishing Ltd.; 2012. p. 101-10.","DOI":"10.1002\/9781119979449.ch11"},{"key":"key-10.4103\/1117-1936.299912-9","first-page":"191","volume-title":"Evaluation and management of severe preeclampsia before 34 weeks' gestation","author":"Publications","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/1117-1936.299912-10","first-page":"291","volume-title":"Perinatal outcome in preeclampsia: A prospective study","author":"Duddamani","year":"2014","journal-title":"Sch J App Med Sci"},{"key":"key-10.4103\/1117-1936.299912-11","first-page":"1322","volume-title":"The association of serum cancer antigen and C-reactive protein level with the severity of preeclampsia","author":"Ali","year":"2012","journal-title":"Karbala J Med"},{"key":"key-10.4103\/1117-1936.299912-12","first-page":"14","volume-title":"Serum concentrations of CA125 in normal and preeclamptic pregnancies","author":"Bhattacharya","year":"2014","journal-title":"J Pharm"},{"key":"key-10.4103\/1117-1936.299912-13","first-page":"1","volume-title":"Serum CA-125 levels in preeclampsia: A systematic review and meta-analysis","author":"Bellos","year":"2019","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/1117-1936.299912-14","unstructured":"Federal Republic of Nigeria Gazette. The Provisional Results of 2006 Census. Vol. 19. Federal Republic of Nigeria Gazette; 2007. p. 182-3."},{"key":"key-10.4103\/1117-1936.299912-15","unstructured":"Kirkwood BR, Sterne JA. Essential Medical Statistics. 2nd ed. USA: Blackwell Publishing Company; 2003. p. 420-21."},{"key":"key-10.4103\/1117-1936.299912-16","first-page":"29","volume-title":"Maternal serum CA-125 level is elevated in severe preeclampsia","author":"Karaman","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"key-10.4103\/1117-1936.299912-17","first-page":"44:2530","volume-title":"Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA125","author":"van","year":"1998","journal-title":"Clin Chem"},{"key":"key-10.4103\/1117-1936.299912-18","unstructured":"Strasing S, Marjorie S. Chemical examination of urine. In: Urinalysis and Body Fluids. 5th ed. Philadelphia: F. A. Davis Company; 2008. p. 59."},{"key":"key-10.4103\/1117-1936.299912-19","doi-asserted-by":"crossref","unstructured":"Ozat M, Kanat Pektas M, Yenicesu O, Gungor T, Danisman N, Mollamahmutoglu L. Serum concentrations of CA125 in normal and preeclamptic pregnancies. Arch Gynecol Obstet 2010;1-9. DOI 10.1007\/s00404-010-1736-2.","DOI":"10.1007\/s00404-010-1736-2"},{"key":"key-10.4103\/1117-1936.299912-20","doi-asserted-by":"crossref","unstructured":"W\u00f3jtowicz A, Szczerba MZ, Babczyk D, Pietruszka MK, Lewaczy\u0144ska O, Hubert Hura H. \u201cEarly- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings according to the New ISHHP Criteria\u201d, International Journal of Hypertension 2019;2019:9. Article ID 4108271.","DOI":"10.1155\/2019\/4108271"},{"key":"key-10.4103\/1117-1936.299912-21","first-page":"201","volume-title":"CA125 and CRP are elevated in Preeclampsia","author":"Cebosay","year":"2009","journal-title":"Hypertens Pregnancy"},{"key":"key-10.4103\/1117-1936.299912-22","first-page":"204","volume-title":"Tumour markers in hypertensive disorders of pregnancy","author":"Schroocksnadel","year":"1993","journal-title":"Gynecol Obstet Invest"},{"key":"key-10.4103\/1117-1936.299912-23","first-page":"166","volume-title":"Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy","author":"Bon","year":"2001","journal-title":"Fetal Diagn Ther"},{"key":"key-10.4103\/1117-1936.299912-24","first-page":"93","volume-title":"Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria?","author":"Osanyin","year":"2018","journal-title":"Hypertens Pregnancy"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:45:28Z","timestamp":1786733128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_241_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["299912"],"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_241_20","relation":{},"ISSN":["1117-1936"],"issn-type":[{"value":"1117-1936","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}